XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 164 filers reported holding XENON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,281,888 | -59.8% | 96,074 | -54.7% | 0.01% | -56.5% |
| Q2 2023 | $8,166,967 | +6.6% | 212,129 | -0.9% | 0.02% | 0.0% |
| Q1 2023 | $7,661,064 | -10.7% | 214,056 | -1.6% | 0.02% | -17.9% |
| Q4 2022 | $8,580,757 | +9.3% | 217,620 | +0.1% | 0.03% | +12.0% |
| Q3 2022 | $7,851,000 | +463.2% | 217,474 | +374.6% | 0.02% | +525.0% |
| Q2 2022 | $1,394,000 | +33.4% | 45,823 | +34.0% | 0.00% | +100.0% |
| Q1 2022 | $1,045,000 | – | 34,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |